Main menu

AACR 2022: The most comprehensive view of the cancer genome


Direct, PCR-free nanopore sequencing offers a unique view into the human genome, allowing single nucleotide variations, structural variations, phasing, epigenetic modifications and more to be examined in a single sequencing dataset. In this session, we explored how these technical benefits can open up a new window of understanding into the cancer genome, featuring projects ranging from new methods of interrogating hereditary cancer predisposition to rapid insights into paediatric leukaemias. Listen now to hear some of the latest from scientists using nanopore sequencing to access new genomic and transcriptomic information, giving an unprecedented view of the mechanisms involved in cancer progression and evolution.

Authors: Fritz Sedlazeck, Sissel Juul, Phillip James & Jeremy Wang

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag